Celltrions Remsima SC praised in Europe as preferred biosimilar
A rheumatologist speaks at a European Congress of Rheumatology symposium hosted by Celltrion on Infliximab IV to SC - Mainstay Therapy in Rheumatology on June 2, 2023 MILAN South Korean…